Genomictree is a molecular diagnostics company. The goal is to develop a novel set of diagnostic system useful for the early detection and stratification of human cancer with epigenetic biomarkers. Cancer diagnostic tests based on epigenetic biomarker will have the biggest future potential in the molecular diagnostic market. We are currently focused on discovering and validating DNA methylation biomarkers for early detection of gastric, lung, cervical, colorectal, breast, bladder and other common cancers in body fluids such as serum or urine. We are trying to make our company as a leading company in the field of molecular diagnostics. We also have superior DNA microarray fabrication technology and provide microarray analysis services from DNA microarray experiment design to data analysis after experiment.
